About: Forte Biosciences, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for autoimmune and autoimmune-related diseases. The company offers products, such as its lead product candidate FB102, a proprietary molecule with applications for celiac disease, vitiligo, and alopecia areata; and services, including the clinical development and management of its Phase 2 clinical trials. Forte Biosciences, Inc. was incorporated in 2007 and is based in Dallas, Texas. As of August 27, 2026, Forte Biosciences, Inc. operates as a subsidiary of argenx SE.
Sector: Healthcare
Industry: Biotechnology
Latest price: $76.99 (+0.03%)
Status: Delisted — removed_from_provider. This asset is no longer trading; historical data is shown.
FBRX NASDAQ Forte Biosciences Inc
Forte Biosciences Inc share price
FBRX price activity
Last Price
Change (24hr)
USD
Volume
-
Volume (4w avg)
-
Previous Close
N/A
Last Trade
FBRX price performance
FBRX Market Signals